Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence C Ku

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Pediatric Research|October 1, 2014
Dosing in neonates: special considerations in physiology and trial designLawrence C Ku, P Brian Smith
Clinics in Perinatology|February 14, 2015
Bacterial meningitis in infantsLawrence C Ku, Kim A Boggess, Michael Cohen-Wolkowiez
Pediatric Cardiology|November 10, 2016
Safety of Enalapril in Infants Admitted to the Neonatal Intensive Care UnitLawrence C Ku, Kanecia Zimmerman, Daniel K Benjamin, et al.
The Pediatric Infectious Disease Journal|April 15, 2017
Use of Population Pharmacokinetics and Electronic Health Records to Assess Piperacillin-Tazobactam Safety in InfantsSara Salerno, Christoph P Hornik, Michael Cohen-Wolkowiez, et al.
Early Human Development|September 8, 2018
Prolonged furosemide exposure and risk of abnormal newborn hearing screen in premature infantsLaura A Wang, P Brian Smith, Matthew Laughon, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 30, 2018
Population Pharmacokinetics and Exploratory Exposure-Response Relationships of Diazepam in Children Treated for Status EpilepticusLawrence C Ku, Christoph P Hornik, Ryan J Beechinor, et al.
Therapeutic Drug Monitoring|October 21, 2016
Use of Therapeutic Drug Monitoring, Electronic Health Record Data, and Pharmacokinetic Modeling to Determine the Therapeutic Index of Phenytoin and LamotrigineLawrence C Ku, Huali Wu, Rachel G Greenberg, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Pediatric Research|October 1, 2014
Dosing in neonates: special considerations in physiology and trial designLawrence C Ku, P Brian Smith
Clinics in Perinatology|February 14, 2015
Bacterial meningitis in infantsLawrence C Ku, Kim A Boggess, Michael Cohen-Wolkowiez
Pediatric Cardiology|November 10, 2016
Safety of Enalapril in Infants Admitted to the Neonatal Intensive Care UnitLawrence C Ku, Kanecia Zimmerman, Daniel K Benjamin, et al.
The Pediatric Infectious Disease Journal|April 15, 2017
Use of Population Pharmacokinetics and Electronic Health Records to Assess Piperacillin-Tazobactam Safety in InfantsSara Salerno, Christoph P Hornik, Michael Cohen-Wolkowiez, et al.
Early Human Development|September 8, 2018
Prolonged furosemide exposure and risk of abnormal newborn hearing screen in premature infantsLaura A Wang, P Brian Smith, Matthew Laughon, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 30, 2018
Population Pharmacokinetics and Exploratory Exposure-Response Relationships of Diazepam in Children Treated for Status EpilepticusLawrence C Ku, Christoph P Hornik, Ryan J Beechinor, et al.
Therapeutic Drug Monitoring|October 21, 2016
Use of Therapeutic Drug Monitoring, Electronic Health Record Data, and Pharmacokinetic Modeling to Determine the Therapeutic Index of Phenytoin and LamotrigineLawrence C Ku, Huali Wu, Rachel G Greenberg, et al.
Pageof 1